Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Melinta Therapeutics to Present at Upcoming Investor Conferences
-
Allena Pharmaceuticals to Present at Upcoming Investor Conferences in October
-
Catalyst Biosciences to Present at Two Upcoming Healthcare Investor Conferences
-
Rhythm Pharmaceuticals to Present at Ladenburg Thalmann 2018 Healthcare Conference
-
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference
-
Allena Pharmaceuticals to Present at Upcoming Investor Conferences in October
-
BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference
-
UroGen Pharma to Present at the Ladenburg Thalmann 2018 Healthcare Conference
-
Lipocine to Present at the Ladenburg Thalmann 2018 Healthcare Conference
-
Rhythm Pharmaceuticals to Present at Ladenburg Thalmann 2018 Healthcare Conference
-
Eiger BioPharmaceuticals to Participate in Investor Conferences
-
Krystal Biotech to Present at Upcoming Cantor Fitzgerald and Ladenburg Thalmann Conferences
-
Arch Therapeutics to Provide Corporate Update at the Ladenburg Thalmann 2018 Healthcare Conference on Tuesday, October 2, 2018
-
Oragenics, Inc. to Present at Upcoming Conferences in October
-
Avadel Pharmaceuticals to Present at the Ladenburg Thalmann 2018 Healthcare Conference
-
Antares Pharma to Present at the Ladenburg Thalmann 2018 Healthcare Conference
-
Alpine Immune Sciences to Present at Ladenburg Thalmann 2018 Healthcare Conference
-
Leap Therapeutics to Present at Two October Conferences
-
Arcturus Therapeutics to Present at October Investor Conferences
-
Rocket Pharmaceuticals Announces Participation at Upcoming Conferences
-
BeiGene to Present at Upcoming Investor Conferences
-
Form 4 LADENBURG THALMANN FINAN For: Sep 20 Filed by: FROST PHILLIP MD ET AL
-
Hercules Capital Closes Public Offering of $40.0 Million 6.25% Notes due 2033
-
Helius Medical Technologies to Participate in Three Upcoming Conferences in October
-
Helius Medical Technologies to Participate in Three Upcoming Conferences in October
-
Cidara Therapeutics to Present at Two Upcoming Investor Conferences
-
Ladenburg Thalmann (LTS) CEO Buys 50K Shares
-
STRATA Skin Sciences to Participate in Ladenburg Thalmann 2018 Healthcare Conference
-
Form 4 LADENBURG THALMANN FINAN For: Sep 21 Filed by: LAMPEN RICHARD
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Pre-Open Movers 09/21: (DTEA) (SCS) (NVAX) Higher; (GTXI) (PIR) (TLRY) Lower (more...)
-
Ladenburg Thalmann (LTS) CEO Richard Lampen to Replace Phillip Frost as Chairman
-
Form 8-K LADENBURG THALMANN FINAN For: Sep 20
-
Molecular Templates (MTEM) Prices 8.2M Share Common Offering at $5.50/Sh
-
Molecular Templates, Inc. Announces Pricing of Public Offering of Common Stock
-
Ladenburg Announces CEO Richard Lampen to Serve as Chairman
-
ContraFect to Present at Two Upcoming Investor Conferences
-
TransEnterix to Participate in Two Upcoming Healthcare Conferences
-
Tenax Therapeutics to Present at Upcoming Investor Conferences
-
Firsthand Technology Value Fund (SVVC) PT Raised to $34 at Ladenburg Thalmann
-
Invitae Corporation (NVTA) PT Raised to $21.75 at Ladenburg Thalmann
-
Exicure, Inc. (XCUR) Reports Positive Phase 1 Results for Lead Immuno-Oncology Asset
-
RedHill Biopharma to Present at Ladenburg Thalmann 2018 Healthcare Conference
-
Intec Pharma to Participate at Upcoming Investment Conferences
-
RedHill Biopharma to Present at Ladenburg Thalmann 2018 Healthcare Conference
-
Exicure Announces Positive Phase 1 Results for its Lead Immuno-Oncology Asset
-
Ovid Therapeutics to Present at Two Investor Healthcare Conferences in October 2018
-
Ovid Therapeutics to Present at Two Investor Healthcare Conferences in October 2018
-
Dynatronics to Participate in Ladenburg Thalmann's Healthcare Conference

